BIONICS

Objective

The purpose of this study is to compare the effectiveness and safety of investigational BioNIR ridaforolimus eluting stent vs. the FDA approved Resolute stent in patients with coronary artery disease.

Location:

Essentia Health Duluth

Disclosures:

None

For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.

Last Updated: 04/22/2017

Research Study Categories

  • Adult Studies

Specialty

  • Cardiology
Contact
Cardiology Clinical Trials at 866-839-4128
or clinicaltrials@essentiahealth.org